logo

GLMD

Galmed
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

GLMD Profile

Galmed Pharmaceuticals Ltd.

A clinical-stage biopharmaceutical company that focused on liver, metabolic, fibrosis and inflammatory diseases

Pharmaceutical
07/31/2013
03/13/2014
NASDAQ Stock Exchange
3
12-31
Common stock
16 Abba Hillel Road, Ramat Gan, Israel 5250608
--
Galmed Pharmaceuticals Ltd., established in Israel on July 31, 2013, is an Israeli private company. The Company is a clinical biopharmaceutical company focused on developing and commercializing a novel, once-daily, orally available drug for the treatment of liver disease and cholesterol firmness.